Tryptophan 2,3 Dioxygenase Pipeline Review, H2 2019
Summary
According to the recently published report 'Tryptophan 2,3 Dioxygenase Pipeline Review, H2 2019'; Tryptophan 2,3 Dioxygenase Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11 pipeline Target constitutes close to 11 molecules.
Tryptophan 2,3 Dioxygenase Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11 Tryptophan 2, 3dioxygenase is an enzyme that plays a critical role in tryptophan metabolism by catalyzing the first and ratelimiting step of the kynurenine pathway. It has specificity towards tryptamine and derivatives including D and Ltryptophan, 5hydroxytryptophan and serotonin.
The report 'Tryptophan 2,3 Dioxygenase Pipeline Review, H2 2019' outlays comprehensive information on the Tryptophan 2,3 Dioxygenase Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action MoA, route of administration RoA and molecule type; that are being developed by Companies / Universities.
It also reviews key players involved in Tryptophan 2,3 Dioxygenase Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11 targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase I, Preclinical and Discovery stages are 3, 7 and 1 respectively. Report covers products from therapy areas Oncology and Central Nervous System which include indications Melanoma, Solid Tumor, Bladder Cancer, Colon Carcinoma, Glioblastoma Multiforme GBM, Head And Neck Cancer, Kidney Cancer Renal Cell Cancer, Lung Cancer, Metastatic Melanoma, NonSmall Cell Lung Cancer and Parkinson's Disease.
Scope
The report provides a snapshot of the global therapeutic landscape for Tryptophan 2,3 Dioxygenase Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11
The report reviews Tryptophan 2,3 Dioxygenase Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industryspecific sources
The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, RD brief, licensing and collaboration details other developmental activities
The report reviews key players involved in Tryptophan 2,3 Dioxygenase Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11 targeted therapeutics and enlists all their major and minor projects
The report assesses Tryptophan 2,3 Dioxygenase Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11 targeted therapeutics based on mechanism of action MoA, route of administration RoA and molecule type
The report summarizes all the dormant and discontinued pipeline projects
The report reviews latest news and deals related to Tryptophan 2,3 Dioxygenase Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11 targeted therapeutics
Reasons to buy
Gain strategically significant competitor information, analysis, and insights to formulate effective RD strategies
Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
Identify and understand the targeted therapy areas and indications for Tryptophan 2,3 Dioxygenase Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11
Identify the use of drugs for target identification and drug repurposing
Identify potential new clients or partners in the target demographic
Develop strategic initiatives by understanding the focus areas of leading companies
Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Tryptophan 2,3 Dioxygenase Tryptamin 2,3 Dioxygenase or Tryptophan Oxygenase or Tryptophan Pyrrolase or Tryptophanase or TDO2 or EC 1.13.11.11 development landscape
Develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope